← Open Payments lookup

ERIC KINSMAN: Open Payments

NPI 1619225083 · FORT POLK, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$411 in 17 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $515 · 2025 $411

Food & beverage: $411
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.7$178
E.R. Squibb & Sons, L.L.C.2$47
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$44
Lundbeck LLC1$29
Teva Pharmaceuticals USA, Inc.1$28
ABBVIE INC.1$23
Neurocrine BioSciences, Inc.1$21
Alkermes, Inc.1$21
Axsome Therapeutics, Inc.1$20

Products named: REXULTI, COBENFY, CAPLYTA, AUSTEDO XR, VRAYLAR, INGREZZA, ARISTADA, Auvelity.

Industry payments across LA — which companies pay providers there.